SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Panacea Biotec receives CDR-EG approval for debt restructuring proposal

29 Sep 2014 Evaluate

Panacea Biotec has received CDR-EG approval for debt restructuring proposal. The Corporate Debt Restructuring Empowered Group (CDR-EG) had in its meeting held on September 09, 2014, approved Panacea Biotec’s Corporate Debt Restructuring (CDR) proposal which was referred to CDR Cell on December 21, 2013 and admitted by CDR -EG on January 24, 2014 and the LOA dated September 24, 2014 had been issued by CDR EG in this regard.

The necessary steps for implementation of the proposal shall be taken in due course of time in coordination with the Lenders.

Panacea Biotec is one of India’s leading research based health management companies with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

358.00 5.30 (1.50%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×